Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Subscribe
Enforcement

Roundup of Q1 2020 Food and Dietary Supplement Warning Letters

April 29, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 4/20/2020: Untitled Letter to Stem Cell Firm

April 27, 2020
Redica Systems
No items found.

Part 2: Analysis of FDA FY2019 Drug GMP Warning Letters

April 23, 2020
Redica Systems
No items found.

Human Cell and Tissue Therapy Enforcement Actions Target Unapproved New Products Making Unsubstantiated Claims

April 23, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 4/13/2020: Compounding Pharmacy

April 21, 2020
Redica Systems
No items found.

Deploying Risk-Based Thinking within Management Systems

April 16, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 4/6/2020: Devices, BIMO

April 14, 2020
Redica Systems
No items found.

March 483s: Most Popular and Newsworthy

April 9, 2020
Redica Systems
No items found.
Trends

Did COVID-19 Kill Just-in-Time Pharma Supply Chains?

April 9, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 3/30/2020: Pharma, Device, GLP, and Compounding Pharmacy

April 7, 2020
Redica Systems
No items found.

CDRH Reorganization Takes a Total Product Lifecycle Approach; MDSAP, ISO Adoption, and Collaboration with MDIC Moving Forward

April 2, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 3/22/2020: OTC and HCT/P

March 31, 2020
Redica Systems
No items found.
Enforcement

EMA Announcements Regarding Nitrosamine and MDRs

March 27, 2020
Redica Systems
No items found.

Big Pharma Puts Patients First in Response to COVID-19 Challenges; Collaboration with Regulators is Essential Going Forward

March 23, 2020
Redica Systems
No items found.

FDA Warning Letters Week of 3/8/2020: BIMO and OTC Products

March 17, 2020
Redica Systems
No items found.
Enforcement

COVID-19 Briefing: Covington & Burling Teleconference

March 17, 2020
Redica Systems
No items found.
Trends

Update: What are Pharma and Med Device Firms Doing About COVID-19?

March 11, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 3/1/2020: Device Design Controls

March 10, 2020
Redica Systems
No items found.

Other Resources

Assessments

Insights on inspections, risk and compliance

Reports

Benchmark industry trends and best practices

Webinars

Hear from industry leaders and Redica experts.